In vitro release of betamethasone dipropionate from petrolatum-based ointments.

The purpose of this research was to develop new in vitro methodology for measuring release from petrolatum-based semisolids and to determine whether two ointments, both of which contained betamethasone dipropionate, 0.05%, but with different formulations, could be distinguished by release measurements. Several receptor media were explored to optimize the procedure utilizing Franz-type cells. Analysis was by HPLC. The release slope was 1.5 to 6 times greater from the ointment than the "augmented" ointment (which had greater clinical potency). Release was highest with a receptor consisting of a 5% solution of hexane in acetonitrile. Even so, it was necessary to subject samples of receptor from the augmented ointment to evaporation followed by reconstitution with a smaller volume of mobile phase to bring corticosteroid concentrations up to quantifiable levels. In another series of experiments, the HPLC mobile phase was used as the receptor and a relatively large volume (100 microliters) was injected onto the column. With the second approach, measured concentrations were lower but more reproducible. Quantifiable levels of betamethasone dipropionate were obtained for both formulations beginning from the first data point (at 1 hr), with satisfactory linearity of plots of amount released per unit area of membrane versus the square root of time. Using this methodology, it was possible to distinguish the effect of formulation differences in two ointments containing the same drug in the same concentration.

Effect of beta-endorphin on steroidogenesis by bovine luteal cells.

To determine if opioid peptides have a local effect on the modulation of progesterone (P4) synthesis, a study was made of the effect of beta-endorphin and leu-enkephalin on P4 production by pure preparations of small luteal cells and dissociated luteal cells comprising both small and large cells from cows 2-3 months pregnant. Corpora lutea were dispersed by collagenase, and the large and small luteal cells were separated using Percoll gradients. Viable luteal cells (5 x 10(5)) were incubated in 0.5 mL of Eagle medium for 2 h at 37 degrees C, in an atmosphere of 5% CO2. Cells were treated with 8-bromoadenosine 3',5'-monophosphate (8Br-cAMP), hCG, beta-endorphin (BE) and leu-enkephalin (LE) alone or in combination. When small luteal cells were used, P4 synthesis was significantly enhanced in the presence of opioid peptides alone (P less than 0.01); there was an additive effect with 8Br-cAMP and with hCG. For dissociated luteal cells, opioid peptides alone had no effect on P4 production but the stimulation of P4 production induced by 8Br-cAMP or hCG was significantly (P less than 0.01) inhibited in the presence of opioid peptides. In contrast, dissociated luteal cells that were preincubated with PGF2 alpha (degranulation) responded to the presence of BE with increased P4 synthesis similar to that seen with the pure preparation of small luteal cells. It is concluded that opioid peptides play an auto/paracrine role in both basal and tropic hormone-induced stimulation of steroidogenesis by the bovine luteal cell.